Oligonucleotides and polyribonucleotides: a review of antiviral activity (Q36124734)

12 August 2017

1 reference

title

Oligonucleotides and polyribonucleotides: a review of antiviral activity (English)

1 reference

12 August 2017

Michael Markosian

1 reference

12 August 2017

Robyn M Hyde

series ordinal

1 reference

12 August 2017

publication date

1 January 2005

1 reference

Antiviral Chemistry & Chemotherapy

12 August 2017

published in

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

12 August 2017

page(s)

91-102

1 reference

beta-Cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

An unusual "senseless" 2',5'-oligoribonucleotide with potent anti-HIV activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Synthesis of novel 3'-C-methylene thymidine and 5-methyluridine/cytidine H-phosphonates and phosphonamidites for new backbone modification of oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

A phase I study of ampligen in human immunodeficiency virus-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Increased uptake of antisense oligonucleotides by delivery as double stranded complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Structure-activity relationships and mode of action of 5-mercapto-substituted oligo- and polynucleotides as antitemplates inhibiting replication of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

4'-Thio-oligo-beta-D-ribonucleotides: synthesis of beta-4'-thio-oligouridylates, nuclease resistance, base pairing properties, and interaction with HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Studies on the toxicity and antiviral activity of various polynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

New and re-emerging cutaneous infectious diseases in Latin America and other geographic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Rapid Diversity‐Oriented Synthesis in Microtiter Plates for In Situ Screening of HIV Protease Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Unusual Single-Stranded Polyribonucleotides as Potent Anti-HIV Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Anti-HIV agents derived from the ent-kaurane diterpenoid linearol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Structural requirements of the rIn·rCn complex for Induction of human interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Molecular approaches to inhibit oncogenesis by RNA tumor viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

2'-O-methyl, 2'-O-ethyl oligoribonucleotides and phosphorothioate oligodeoxyribonucleotides as inhibitors of the in vitro U7 snRNP-dependent mRNA processing event

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Topical polyriboinosinic-polyribocytidylic acid complex in the treatment of recurrent genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Antisense oligodeoxynucleotide: inhibitor of splicing of mRNA of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Antisense oligonucleotide-based therapeutics for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Inhibition of oncornavirus functions by poly (2-methylthioinosinic acid)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Novel cationic amphiphiles as delivery agents for antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Antisense oligodeoxynucleotides against the BZLF1 transcript inhibit induction of productive Epstein-Barr virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Novel non-endocytic delivery of antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Locked nucleic acid containing antisense oligonucleotides enhance inhibition of HIV-1 genome dimerization and inhibit virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Mismatched double-stranded RNA (polyI-polyC(12)U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Infectious Diseases: Considerations for the 21st Century

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Inhibition of rabies virus infection by an oligodeoxynucleotide complementary to rabies virus genomic RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Antisense oligonucleotides as therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Avian influenza virus infection of children in Vietnam and Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Oligonucleotide N3'-->P5' phosphoramidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Can HIV be Cured? Mechanisms of HIV persistence and strategies to combat it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Ketones as building blocks for dynamic combinatorial libraries: highly active neuraminidase inhibitors generated via selection pressure of the biological target

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Applying antisense technology: Affinitak and other antisense oligonucleotides in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

RNA interference against retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

"Senseless" antiviral polyribonucleotides: poly (1-propargylinosinic acid).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Antiviral Amphipathic Oligo- and Polyribonucleotides: Analogue Development and Biological Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Progress in the development of nucleic acid therapeutics for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Duplex stabilities of phosphorothioate, methylphosphonate, and RNA analogs of two DNA 14-mers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Cancer immunotherapy: the interferon-alpha experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

DNA analogues: from supramolecular principles to biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Prophylactic Control of Simian Hemorrhagic Fever in Monkeys by an Interferon Inducer, Polyriboinosinic-Polyribocytidylic Acid-Poly-L-Lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Topical treatment of vaccinia virus infection with an interferon inducer in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Interferons, Interferon Inducers, and Interferon-Ribavirin in Treatment of Flavivirus-Induced Encephalitis in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Innovations in oligonucleotide drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Epstein-Barr Virus and Herpesvirus saimiri: Sensitivity to Interferons and Interferon Inducers2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

2'-carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

RNA interference in biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Current concepts in antisense drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

The challenge of emerging and re-emerging infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

A new peptide vector for efficient delivery of oligonucleotides into mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Antisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

The effect of combinations of ampligen and zidovudine or dideoxyinosine against human immunodeficiency viruses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Oxetane modified, conformationally constrained, antisense oligodeoxyribonucleotides function efficiently as gene silencing molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Progress in meeting today's demands in genital herpes: an overview of current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

The nature of interferon-alpha resistance in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Prospects for antiviral ribozymes and deoxyribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Comparative study of various immunomodulators for macrophage and natural killer cell activation and antiviral efficacy against exotic RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Antisense therapeutics: from theory to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

2'-O-[2-(methylthio)ethyl]-modified oligonucleotide: an analogue of 2'-O-[2-(methoxy)-ethyl]-modified oligonucleotide with improved protein binding properties and high binding affinity to target RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Antisense oligonuclotides with oxetane-constrained cytidine enhance heteroduplex stability, and elicit satisfactory RNase H response as well as showing improved resistance to both exo and endonucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

3'-methylphosphonate-modified oligo-2'-O-methylribonucleotides and their Tat peptide conjugates: uptake and stability in mouse fibroblasts in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Reading, writing, and modulating genetic information with boranophosphate mimics of nucleotides, DNA, and RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Antisense properties of tricyclo-DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

SARS: epidemiology, clinical presentation, management, and infection control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Postinfection therapy of arbovirus infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Effect of a Nuclease-Resistant Derivative of PolyriboinosinicPolyribocytidylic Acid Complex on Yellow Fever in Rhesus Monkeys (Macaca mulatta)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Protective and Toxic Effects of a Nuclease-Resistant Derivative of Polyriboinosinic.Polyribocytidylic Acid on Venezuelan Equine Encephalomyelitis Virus in Rhesus Monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Morpholino antisense oligomers: design, preparation, and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Morpholino antisense oligomers: the case for an RNase H-independent structural type

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Antiviral oligo- and polyribonucleotides containing selected triazolo[2,3-a]purines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Managing resistance to anti-HIV drugs: an important consideration for effective disease management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

RNase H mediated cleavage of RNA by cyclohexene nucleic acid (CeNA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Inhibition of hepatitis viral replication by siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Toxic Properties of a Synthetic Double-stranded RNA: Endotoxin-like Properties of Poly I.Poly C, an Interferon Stimulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

Toxic Properties of a Synthetic Double-stranded RNA: Pyrogenicity of Poly I.Poly C in Rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600202

10.1177/095632020501600202

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference